Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
deals
fda
4
×
life sciences
national blog main
startups
4
×
biotech
food and drug administration
national top stories
boston blog main
new york blog main
new york top stories
raleigh-durham blog main
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
wisconsin blog main
wisconsin top stories
abbvie
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amunix
anirvan ghosh
astrazeneca
atrial fibrillation
biogen
bluerock therapeutics
boston
boston scientific
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cerovene
clinical trial
clinical trials
covid-19
What
deal
4
×
startup
acquire
acquisitions
adding
announced
appear
atrial
biggest
bio
boston
building
business
ceo
collabs
companies
continues
covid
cryterion
daniel
deerfield
developer
device
didn't
disease
drug
end
established
eyeing
fibrillation
firm
gilead
gilead’s
happening
heart
help
introduce
investment
involved
ipo
Language
unset
Current search:
fda
×
startups
×
deal
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
After Deal Stalled, Shine Medical Eyeing Up to $160M from Deerfield
@xconomy.com
5 years ago
Boston Scientific Continues M&A Streak with $202M Deal for Cryterion
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed